Saturday, January 20, 2024 7:36:15 AM
Recent AZTR News
- Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates • PR Newswire (US) • 11/12/2024 10:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:01:49 PM
- Azitra to Present at BIO-Europe 2024 • Business Wire • 10/29/2024 01:00:00 PM
- Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit • Business Wire • 10/11/2024 01:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/09/2024 09:01:27 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/09/2024 08:55:38 PM
- Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress • Business Wire • 09/24/2024 12:00:00 PM
- Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors • Business Wire • 09/18/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 09:47:39 PM
- Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 09/06/2024 08:30:00 PM
- Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome • Business Wire • 08/28/2024 12:30:00 PM
- Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors • Business Wire • 08/22/2024 01:00:00 PM
- Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome • Business Wire • 08/20/2024 08:15:00 PM
- Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates • Business Wire • 08/12/2024 10:23:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 09:15:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 09:02:51 PM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/02/2024 08:05:42 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 07/29/2024 08:01:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:05:15 PM
- CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering • Business Wire • 07/25/2024 09:57:00 PM
- Azitra, Inc. Announces Closing of Public Offering • Business Wire • 07/25/2024 06:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/25/2024 10:03:57 AM
- Azitra, Inc. Announces Pricing of $10.0 Million Public Offering • Business Wire • 07/24/2024 01:20:00 AM
- Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents • Business Wire • 07/23/2024 12:00:00 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM